{
    "references": [
        {
            "bibentry": "Giacobini, E. Invited review cholinesterase inhibitors for Alzheimer’s disease therapy: from tacrine to future applications. Neurochem Int 1998; 32: 413–9. PMID: 9676739",
            "process_entry": "True",
            "doi": "10.1016/s0197-0186(97)00124-1",
            "pmid": "9676739",
            "xmlid": "CIT0001"
        },
        {
            "bibentry": "Shaw, FH, Bentley, G. Morphine antagonism. Nature 1952; 169: 712–3. PMID: 14956997",
            "process_entry": "True",
            "doi": "10.1038/169712a0",
            "pmid": "14956997",
            "xmlid": "CIT0002"
        },
        {
            "bibentry": "Hunter, AJ, Murray, TK, Jones, JA, et al. The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro. Br J Pharm 1989; 98: 79–86.",
            "process_entry": "True",
            "xmlid": "CIT0003"
        },
        {
            "bibentry": "Zovko, A, Sepcic, K, Turk, T, et al. New aspects of the relationship between acetylcholinesterase activity and cancer I. Poly-Aps Exp 2009; 6: 58–69.",
            "process_entry": "True",
            "xmlid": "CIT0004"
        },
        {
            "bibentry": "Soukup, O, Jun, D, Zdarova-Karasova, J, et al. A resurrection of 7-MEOTA: a comparison with tacrine. Curr Alzh Res 2013; 10: 893–906.",
            "process_entry": "True",
            "xmlid": "CIT0005"
        },
        {
            "bibentry": "Summers, WK, Majovski, LV, Marsh, GM, et al. Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. N Engl J Med 1986; 315: 1241–5. PMID: 2430180",
            "process_entry": "True",
            "doi": "10.1056/nejm198611133152001",
            "pmid": "2430180",
            "xmlid": "CIT0006"
        },
        {
            "bibentry": "Watkins, PB, Zimmerman, HJ, Knapp, MJ, et al. Hepatotoxic effects of tacrine administration in patients with Alzheimers disease. J Am Med Assoc 1994; 271: 992–8.",
            "process_entry": "True",
            "xmlid": "CIT0007"
        },
        {
            "bibentry": "Kozurkova, M, Hamulakova, S, Gazova, Z, et al. Neuroactive multifunctional tacrine congeners with cholinesterase, anti-amyloid aggregation and neuroprotective properties. Pharm 2011; 4: 382–418.",
            "process_entry": "True",
            "xmlid": "CIT0008"
        },
        {
            "bibentry": "Patocka, J, Jun, D, Kuca, K. Possible role of hydroxylated metabolites of tacrine in drug toxicity and therapy of Alzheimer’s disease. Curr Drug Metab 2008; 9: 332–5. PMID: 18473751",
            "process_entry": "True",
            "doi": "10.2174/138920008784220619",
            "pmid": "18473751",
            "xmlid": "CIT0009"
        },
        {
            "bibentry": "Ezoulin, MJM, Dong, CZ, Liu, Z, et al. Study of PMS777, a new type of acetylcholinesterase inhibitor, in human HepG2 cells. Comparison with tacrine and galanthamine on oxidative stress and mitochondrial impairment. Toxicol In Vitro 2006; 20: 824–31. PMID: 16472967",
            "process_entry": "True",
            "doi": "10.1016/j.tiv.2006.01.002",
            "pmid": "16472967",
            "xmlid": "CIT0010"
        },
        {
            "bibentry": "Galisteo, M, Rissel, M, Sergent, O, et al. Hepatotoxicity of tacrine: occurrence of membrane fluidity alterations without involvement of lipid peroxidation. J Pharmacol Exp Ther 2000; 294: 160–7. PMID: 10871308",
            "process_entry": "True",
            "pmid": "10871308",
            "xmlid": "CIT0011"
        },
        {
            "bibentry": "Osseni, RA, Debbasch, C, Christen, MO, et al. Tacrine-induced reactive oxygen species in a human liver cell line: the role of anethole dithiolethione as a scavenger. Toxicol In Vitro 1999; 13: 683–8. PMID: 20654534",
            "process_entry": "True",
            "doi": "10.1016/s0887-2333(99)00050-8",
            "pmid": "20654534",
            "xmlid": "CIT0012"
        },
        {
            "bibentry": "Robertson, DG, Braden, TK, Urda, ER, et al. Elucidation of mitochondrial effects by tetrahydroaminoacridine (tacrine) in rat, dog, monkey and human hepatic parenchymal cells. Arch Toxicol 1998; 72: 362–71. PMID: 9657284",
            "process_entry": "True",
            "doi": "10.1007/s002040050515",
            "pmid": "9657284",
            "xmlid": "CIT0013"
        },
        {
            "bibentry": "Gazova, Z, Soukup, O, Sepsova, V, et al. Multi-target-directed therapeutic potential of 7-methoxytacrine-adamantylamine heterodimers in the Alzheimer’s disease treatment. Biochim Biophys Acta Mol Basis Dis 2017; 1863: 607–19. PMID: 27865910",
            "process_entry": "True",
            "doi": "10.1016/j.bbadis.2016.11.020",
            "pmid": "27865910",
            "xmlid": "CIT0014"
        },
        {
            "bibentry": "Nepovimova, E, Korabecny, J, Dolezal, R, et al. Tacrine-trolox hybrids: a novel class of centrally active, nonhepatotoxic multi-target-directed ligands exerting anticholinesterase and antioxidant activities with low in vivo toxicity. J Med Chem 2015; 58: 8985–9003. PMID: 26503905",
            "process_entry": "True",
            "doi": "10.1021/acs.jmedchem.5b01325",
            "pmid": "26503905",
            "xmlid": "CIT0015"
        },
        {
            "bibentry": "Nepovimova, E, Uliassi, E, Korabecny, J, et al. Multitarget drug design strategy: quinone-tacrine hybrids designed to block amyloid-β aggregation and to exert anticholinesterase and antioxidant effects. J Med Chem 2014; 57: 8576–89. PMID: 25259726",
            "process_entry": "True",
            "doi": "10.1021/jm5010804",
            "pmid": "25259726",
            "xmlid": "CIT0016"
        },
        {
            "bibentry": "Spilovska, K, Korabecny, J, Nepovimova, E, et al. Multitarget tacrine hybrids with neuroprotective properties to confront Alzheimer’s disease. Curr Top Med Chem 2017; 17: 1006–26. PMID: 27697055",
            "process_entry": "True",
            "doi": "10.2174/1568026605666160927152728",
            "pmid": "27697055",
            "xmlid": "CIT0017"
        },
        {
            "bibentry": "Tumiatti, V, Minarini, A, Bolognesi, ML, et al. Tacrine derivatives and Alzheimer’s disease. Curr Med Chem 2010; 17: 1825–38. PMID: 20345341",
            "process_entry": "True",
            "doi": "10.2174/092986710791111206",
            "pmid": "20345341",
            "xmlid": "CIT0018"
        },
        {
            "bibentry": "Dejmek, L. 7-MEOTA. Drugs Future 1990; 15: 126–9.",
            "process_entry": "True",
            "xmlid": "CIT0019"
        },
        {
            "bibentry": "Koupilova, M, Hrdina, V, Fusek, J. Exploitation of the antagonistic properties of some drugs against poisoning with psychochemicals. Activitas Nervosa Superior 1981; 23: 292–3. PMID: 7336867",
            "process_entry": "True",
            "pmid": "7336867",
            "xmlid": "CIT0020"
        },
        {
            "bibentry": "Bajgar, J, Fusek, J, Patoka, J, Hrdina, V. Protective effect of 9-amino-7-methoxy-1,2,3,4-tetra-hydroacridine against inhibition of acetylcholinesterase by o-ethyl s-(2-dimethylaminoethyl) methylphosphonotioate in vivo. Arch Toxicol 1983; 54: 163–6. PMID: 6651529",
            "process_entry": "True",
            "doi": "10.1007/bf01261385",
            "pmid": "6651529",
            "xmlid": "CIT0021"
        },
        {
            "bibentry": "Mansouri, A, Haouzi, D, Descatoire, V, et al. Tacrine inhibits topoisomerases and DNA synthesis to cause mitochondrial DNA depletion and apoptosis in mouse liver. Hepatology 2003; 38: 715–25. PMID: 12939598",
            "process_entry": "True",
            "doi": "10.1053/jhep.2003.50353",
            "pmid": "12939598",
            "xmlid": "CIT0022"
        },
        {
            "bibentry": "Freudenreich, CH, Kreuzer, KN. Localization of an aminoacridine antitumor agent in a type-ii topoisomerase DNA complex. Proc Natl Acad Sci USA 1994; 91: 11007–11. PMID: 7971998",
            "process_entry": "True",
            "doi": "10.1073/pnas.91.23.11007",
            "pmid": "7971998",
            "pmcid": "PMC45155",
            "xmlid": "CIT0023"
        },
        {
            "bibentry": "Li, TK, Liu, LF. Tumor cell death induced by topoisomerase-targeting drugs. Ann Rev Pharm Toxicol 2001; 41: 53–77.",
            "process_entry": "True",
            "xmlid": "CIT0024"
        },
        {
            "bibentry": "Lin, JH, Castora, FJ. DNA topoisomerase II from mammalian mitochondria is inhibited by the antitumor drugs, m-AMSA and VM-26. Biochem Biophys Res Commun 1991; 176: 690–7. PMID: 1851000",
            "process_entry": "True",
            "doi": "10.1016/s0006-291x(05)80239-6",
            "pmid": "1851000",
            "xmlid": "CIT0025"
        },
        {
            "bibentry": "Skladanowski, A, Plisov, SY, Konopa, J, Larsen, AK. Inhibition of DNA topoisomerase II by imidazoacridinones, new antineoplastic agents with strong activity against solid tumors. Mol Pharmacol 1996; 49: 772–80. PMID: 8622625",
            "process_entry": "True",
            "pmid": "8622625",
            "xmlid": "CIT0026"
        },
        {
            "bibentry": "Chen, TK, Fico, R, Canellakis, ES. Diacridines, bifunctional intercalators. Chemistry and antitumor activity. J Med Chem 1978; 21: 868–74. PMID: 722754",
            "process_entry": "True",
            "doi": "10.1021/jm00207a006",
            "pmid": "722754",
            "xmlid": "CIT0027"
        },
        {
            "bibentry": "Denny, WA. DNA-intercalating ligands as anti-cancer drugs: prospects for future design. Anti-Cancer Drug Design 1989; 4: 241–63. PMID: 2695099",
            "process_entry": "True",
            "pmid": "2695099",
            "xmlid": "CIT0028"
        },
        {
            "bibentry": "Janočková, J, Plšíková, J, Koval’, J, et al. Tacrine derivatives as dual topoisomerase I and II catalytic inhibitors. Bioorg Chem 2015; 59: 168–76. PMID: 25827869",
            "process_entry": "True",
            "doi": "10.1016/j.bioorg.2015.03.002",
            "pmid": "25827869",
            "xmlid": "CIT0029"
        },
        {
            "bibentry": "Bailly, C. Homocamptothecins: potent topoisomerase I inhibitors and promising anticancer drugs. Crit Rev Oncol Hematol 2003; 45: 91–108. PMID: 12482574",
            "process_entry": "True",
            "doi": "10.1016/s1040-8428(02)00090-2",
            "pmid": "12482574",
            "xmlid": "CIT0030"
        },
        {
            "bibentry": "Salerno, S, Da Settimo, F, Taliani, S, et al. Recent advances in the development of dual topoisomerase I and II inhibitors as anticancer drugs. Curr Med Chem 2010; 17: 4270–90. PMID: 20939813",
            "process_entry": "True",
            "doi": "10.2174/092986710793361252",
            "pmid": "20939813",
            "xmlid": "CIT0031"
        },
        {
            "bibentry": "Elmore, S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007; 35: 495–516. PMID: 17562483",
            "process_entry": "True",
            "doi": "10.1080/01926230701320337",
            "pmid": "17562483",
            "pmcid": "PMC2117903",
            "xmlid": "CIT0032"
        },
        {
            "bibentry": "Fox, JL, MacFarlane, M. Targeting cell death signalling in cancer: minimising ‘collateral damage’. Br J Cancer 2016; 115: 5–11. PMID: 27140313",
            "process_entry": "True",
            "doi": "10.1038/bjc.2016.111",
            "pmid": "27140313",
            "pmcid": "PMC4931361",
            "xmlid": "CIT0033"
        },
        {
            "bibentry": "Ghobrial, IM, Witzig, TE, Adjei, AA. Targeting apoptosis pathways in cancer therapy. Cancer J Clin 2005; 55: 178–94.",
            "process_entry": "True",
            "xmlid": "CIT0034"
        },
        {
            "bibentry": "Andrs, M, Korabecny, J, Jun, D, et al. Phosphatidylinositol 3-kinase (PI3K) and phosphatidylinositol 3-kinase-related kinase (PIKK) inhibitors: importance of the morpholine ring. J Med Chem 2015; 58: 41–71. PMID: 25387153",
            "process_entry": "True",
            "doi": "10.1021/jm501026z",
            "pmid": "25387153",
            "xmlid": "CIT0035"
        },
        {
            "bibentry": "Papaphilis, AD, Shaw, YH. Interaction of acridines and tetrahydroacridines with DNA at low DNA/dye ratios. Biochim Biophys Acta 1977; 476: 122–30. PMID: 861227",
            "process_entry": "True",
            "doi": "10.1016/0005-2787(77)90089-2",
            "pmid": "861227",
            "xmlid": "CIT0036"
        },
        {
            "bibentry": "Crenshaw, JM, Graves, DE, Denny, WA. Interactions of acridine antitumor agents with DNA: binding energies and groove preferences. Biochemistry 1995; 34: 13682–7. PMID: 7577959",
            "process_entry": "True",
            "doi": "10.1021/bi00041a050",
            "pmid": "7577959",
            "xmlid": "CIT0037"
        },
        {
            "bibentry": "Nelson, EM, Tewey, KM, Liu, LF. Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide. Proc Natl Acad Sci USA 1984; 81: 1361–5. PMID: 6324188",
            "process_entry": "True",
            "doi": "10.1073/pnas.81.5.1361",
            "pmid": "6324188",
            "pmcid": "PMC344833",
            "xmlid": "CIT0038"
        },
        {
            "bibentry": "Korabecny, J, Dolezal, R, Cabelova, P, et al. 7-MEOTA-donepezil like compounds as cholinesterase inhibitors: synthesis, pharmacological evaluation, molecular modeling and QSAR studies. Eur J Med Chem 2014; 82: 426–38. PMID: 24929293",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2014.05.066",
            "pmid": "24929293",
            "xmlid": "CIT0039"
        },
        {
            "bibentry": "Spilovska, K, Korabecny, J, Kral, J, et al. 7-Methoxytacrine-adamantylamine heterodimers as cholinesterase inhibitors in Alzheimer’s disease treatment –synthesis, biological evaluation and molecular modeling studies. Molecules 2013; 18: 2397–418. PMID: 23429378",
            "process_entry": "True",
            "doi": "10.3390/molecules18022397",
            "pmid": "23429378",
            "pmcid": "PMC6270602",
            "xmlid": "CIT0040"
        },
        {
            "bibentry": "Hamulakova, S, Janovec, L, Hrabinova, M, et al. Synthesis, design and biological evaluation of novel highly potent tacrine congeners for the treatment of Alzheimer’s disease. Eur J Med Chem 2012; 55: 23–31. PMID: 22818849",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2012.06.051",
            "pmid": "22818849",
            "xmlid": "CIT0041"
        },
        {
            "bibentry": "Los, M, Burek, CJ, Stroh, C, et al. Anticancer drugs of tomorrow: apoptotic pathways as targets for drug design. Drug Discov Today 2003; 8: 67–77. PMID: 12565009",
            "process_entry": "True",
            "doi": "10.1016/s1359-6446(02)02563-1",
            "pmid": "12565009",
            "xmlid": "CIT0042"
        },
        {
            "bibentry": "Gottlieb, E, Armour, SM, Harris, MH, Thompson, CB. Mitochondrial membrane potential regulates matrix configuration and cytochrome c release during apoptosis. Cell Death Different 2003; 10: 709–17.",
            "process_entry": "True",
            "xmlid": "CIT0043"
        },
        {
            "bibentry": "Zhang, B, Li, X, Li, B, et al. Acridine and its derivatives: a patent review (2009–2013). Exp Opin Therap Patents 2014; 24: 647–64.",
            "process_entry": "True",
            "xmlid": "CIT0044"
        },
        {
            "bibentry": "Hsiang, YH, Lihou, MG, Liu, LF. Arrest of replication forks by drug-stabilized topoisomerase i-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Res 1989; 49: 5077–82. PMID: 2548710",
            "process_entry": "True",
            "pmid": "2548710",
            "xmlid": "CIT0045"
        },
        {
            "bibentry": "Zhu, HJ, Gooderham, NJ. Mechanisms of induction of cell cycle arrest and cell death by cryptolepine in human lung adenocarcinoma A549 cells. Toxicol Sci 2006; 91: 132–9. PMID: 16510557",
            "process_entry": "True",
            "doi": "10.1093/toxsci/kfj146",
            "pmid": "16510557",
            "xmlid": "CIT0046"
        },
        {
            "bibentry": "Hu, MK. Synthesis and in-vitro anticancer evaluation of bis-tacrine congeners. J Pharm Pharmacol 2001; 53: 83–8. PMID: 11206196",
            "process_entry": "True",
            "doi": "10.1211/0022357011775046",
            "pmid": "11206196",
            "xmlid": "CIT0047"
        },
        {
            "bibentry": "Spicer, JA, Gamage, SA, Rewcastle, GW, et al. Bis(phenazine-1-carboxamides): structure − activity relationships for a new class of dual topoisomerase I/II-directed anticancer drugs. J Med Chem 2000; 43: 1350–8. PMID: 10753472",
            "process_entry": "True",
            "doi": "10.1021/jm990423f",
            "pmid": "10753472",
            "xmlid": "CIT0048"
        },
        {
            "bibentry": "Braña, MF, Castellano, JM, Perron, D, et al. Chromophore-modified bis-naphthalimides: synthesis and antitumor activity of bis-dibenz[de,h]isoquinoline-1,3-diones. J Med Chem 1997; 40: 449–54. PMID: 9046334",
            "process_entry": "True",
            "doi": "10.1021/jm960295k",
            "pmid": "9046334",
            "xmlid": "CIT0049"
        },
        {
            "bibentry": "Hallgas, B, Patonay, T, Kiss-Szikszai, A, et al. Comparison of measured and calculated lipophilicity of substituted aurones and related compounds. J Chromatogr B Anal Technol Biomed Life Sci 2004; 801: 229–35.",
            "process_entry": "True",
            "xmlid": "CIT0050"
        },
        {
            "bibentry": "Alonso, C, Fuertes, M, Gonzalez, M, et al. Synthesis and biological evaluation of indeno[1,5]naphthyridines as topoisomerase I (TopI) inhibitors with antiproliferative activity. Eur J Med Chem 2016; 115: 179–90. PMID: 27017547",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2016.03.031",
            "pmid": "27017547",
            "xmlid": "CIT0051"
        },
        {
            "bibentry": "Goodell, JR, Madhok, AA, Hiasa, H, Ferguson, DM. Synthesis and evaluation of acridine-and acridone-based anti-herpes agents with topoisomerase activity. Bioorg Med Chem 2006; 14: 5467–80. PMID: 16713270",
            "process_entry": "True",
            "doi": "10.1016/j.bmc.2006.04.044",
            "pmid": "16713270",
            "xmlid": "CIT0052"
        },
        {
            "bibentry": "Kumar, A, Ehrenshaft, M, Tokar, EJ, et al. Nitric oxide inhibits topoisomerase II activity and induces resistance to topoisomerase II-poisons in human tumor cells. Biochim Biophys Acta General Subjects 2016; 1860: 1519–27.",
            "process_entry": "True",
            "xmlid": "CIT0053"
        },
        {
            "bibentry": "Wethington, SL, Wright, JD, Herzog, TJ. Key role of topoisomerase I inhibitors in the treatment of recurrent and refractory epithelial ovarian carcinoma. Exp Rev Anticancer Ther 2008; 8: 819–31.",
            "process_entry": "True",
            "xmlid": "CIT0054"
        },
        {
            "bibentry": "Ikeguchi, M, Arai, Y, Maeta, Y, et al. Topoisomerase I expression in tumors as a biological marker for CPT-11 chemosensitivity in patients with colorectal cancer. Surgery Today 2011; 41: 1196–9. PMID: 21874414",
            "process_entry": "True",
            "doi": "10.1007/s00595-011-4546-7",
            "pmid": "21874414",
            "xmlid": "CIT0055"
        },
        {
            "bibentry": "McClendon, AK, Osheroff, N. DNA topoisomerase II, genotoxicity, and cancer. Mutat Res Fund Mol Mechan Mutag 2007; 623: 83–97.",
            "process_entry": "True",
            "xmlid": "CIT0056"
        },
        {
            "bibentry": "Topcu, Z. DNA topoisomerases as targets for anticancer drugs. J Clin Pharm Therap 2001; 26: 405–16. PMID: 11722677",
            "process_entry": "True",
            "doi": "10.1046/j.1365-2710.2001.00368.x",
            "pmid": "11722677",
            "xmlid": "CIT0057"
        },
        {
            "bibentry": "Vos, SM, Tretter, EM, Schmidt, BH, Berger, JM. All tangled up: how cells direct, manage and exploit topoisomerase function. Nat Rev Mol Cell Biol 2011; 12: 827–41. PMID: 22108601",
            "process_entry": "True",
            "doi": "10.1038/nrm3228",
            "pmid": "22108601",
            "pmcid": "PMC4351964",
            "xmlid": "CIT0058"
        },
        {
            "bibentry": "Janockova, J, Gulasova, Z, Plsikova, J, et al. Interaction of cholinesterase modulators with DNA and their cytotoxic activity. Int J Biol Macrom 2014; 64: 53–62.",
            "process_entry": "True",
            "xmlid": "CIT0059"
        },
        {
            "bibentry": "Larsen, AK, Escargueil, AE, Skladanowski, A. Catalytic topoisomerase II inhibitors in cancer therapy. Pharmacol Ther 2003; 99: 167–81. PMID: 12888111",
            "process_entry": "True",
            "doi": "10.1016/s0163-7258(03)00058-5",
            "pmid": "12888111",
            "xmlid": "CIT0060"
        },
        {
            "bibentry": "Baviskar, AT, Amrutkar, SM, Trivedi, N, et al. Switch in site of inhibition: a strategy for structure-based discovery of human topoisomerase IIalpha catalytic inhibitors. ACS Med Chem Lett 2015; 6: 481–5. PMID: 25941559",
            "process_entry": "True",
            "doi": "10.1021/acsmedchemlett.5b00040",
            "pmid": "25941559",
            "pmcid": "PMC4416441",
            "xmlid": "CIT0061"
        },
        {
            "bibentry": "Vispe, S, Vandenberghe, I, Robin, M, et al. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome. Biochem Pharmacol 2007; 73: 1863–72. PMID: 17391647",
            "process_entry": "True",
            "doi": "10.1016/j.bcp.2007.02.016",
            "pmid": "17391647",
            "xmlid": "CIT0062"
        },
        {
            "bibentry": "Nitiss, JL. Targeting DNA topoisomerase II in cancer chemotherapy. Nat Rev Cancer 2009; 9: 338–50. PMID: 19377506",
            "process_entry": "True",
            "doi": "10.1038/nrc2607",
            "pmid": "19377506",
            "pmcid": "PMC2748742",
            "xmlid": "CIT0063"
        },
        {
            "bibentry": "Denny, WA. Emerging DNA topoisomerase inhibitors as anticancer drugs. Exp Opin Emerg Drugs 2004; 9: 105–33.",
            "process_entry": "True",
            "xmlid": "CIT0064"
        },
        {
            "bibentry": "Jensen, PB, Sehested, M. DNA topoisomerase II rescue by catalytic inhibitors: a new strategy to improve the antitumor selectivity of etoposide. Biochem Pharmacol 1997; 54: 755–9. PMID: 9353129",
            "process_entry": "True",
            "doi": "10.1016/s0006-2952(97)00116-0",
            "pmid": "9353129",
            "xmlid": "CIT0065"
        },
        {
            "bibentry": "Koceva-Chyla, A, Jedrzejczak, M, Skierski, J, et al. Mechanisms of induction of apoptosis by anthraquinone anticancer drugs aclarubicin and mitoxantrone in comparison with doxorubicin: relation to drug cytotoxicity and caspase-3 activation. Apoptosis 2005; 10: 1497–514. PMID: 16215684",
            "process_entry": "True",
            "doi": "10.1007/s10495-005-1540-9",
            "pmid": "16215684",
            "xmlid": "CIT0066"
        },
        {
            "bibentry": "Lu, Z, Wientjes, TSS, Au, JS. Nontoxic suramin treatments enhance docetaxel activity in chemotherapy-pretreated non-small cell lung xenograft tumors. Pharm Res 2005; 22: 1069–78. PMID: 16028007",
            "process_entry": "True",
            "doi": "10.1007/s11095-005-6038-1",
            "pmid": "16028007",
            "xmlid": "CIT0067"
        },
        {
            "bibentry": "Yoshida, M, Maehara, Y, Sugimachi, K. MST-16, a novel bis-dioxopiperazine anticancer agent, ameliorates doxorubicin-induced acute toxicity while maintaining antitumor efficacy. Clin Cancer Res 1999; 5: 4295–300. PMID: 10632373",
            "process_entry": "True",
            "pmid": "10632373",
            "xmlid": "CIT0068"
        },
        {
            "bibentry": "Sarwar, T, Rehman, SU, Husain, MA, et al. Interaction of coumarin with calf thymus DNA: deciphering the mode of binding by in vitro studies. Int J Biol Macrom 2015; 73: 9–16.",
            "process_entry": "True",
            "xmlid": "CIT0069"
        },
        {
            "bibentry": "Vantova, Z, Paulikova, H, Sabolova, D, et al. Cytotoxic activity of acridin-3,6-diyl dithiourea hydrochlorides in human leukemia line HL-60 and resistant subline HL-60/ADR. Int J Biol Macromol 2009; 45: 174–80. PMID: 19414028",
            "process_entry": "True",
            "doi": "10.1016/j.ijbiomac.2009.04.018",
            "pmid": "19414028",
            "xmlid": "CIT0070"
        },
        {
            "bibentry": "Kozurkova, M, Sabolova, D, Janovec, L, et al. Cytotoxic activity of proflavine diureas: synthesis, antitumor, evaluation and DNA binding properties of 1',1''-(acridin-3,6-diyl)-3',3''-dialkyldiureas. Bioorg Med Chem 2008; 16: 3976–84. PMID: 18258438",
            "process_entry": "True",
            "doi": "10.1016/j.bmc.2008.01.026",
            "pmid": "18258438",
            "xmlid": "CIT0071"
        },
        {
            "bibentry": "Chaveerach, U, Meenongwa, A, Trongpanich, Y, et al. DNA binding and cleavage behaviors of copper(II) complexes with amidino-O-methylurea and N-methylphenyl-amidino-O-methylurea, and their antibacterial activities. Polyhedron 2010; 29: 731–8.",
            "process_entry": "True",
            "xmlid": "CIT0072"
        },
        {
            "bibentry": "Tao, M, Zhang, GW, Xiong, CH, Pan, JH. Characterization of the interaction between resmethrin and calf thymus DNA in vitro. New J Chem 2015; 39: 3665–74.",
            "process_entry": "True",
            "xmlid": "CIT0073"
        },
        {
            "bibentry": "Janockova, J, Zilecka, E, Kasparkova, J, et al. Assessment of DNA-binding affinity of cholinesterase reactivators and electrophoretic determination of their effect on topoisomerase I and II activity. Mol Biosys 2016; 12: 2910–20.",
            "process_entry": "True",
            "xmlid": "CIT0074"
        },
        {
            "bibentry": "Lakowicz, JR. Principles of fluorescence spectroscopy In, Lakowicz, JR, ed. Quenching of fluorescence. Boston, MA: Springer US; 2006: 277–330.",
            "process_entry": "True",
            "xmlid": "CIT0075"
        },
        {
            "bibentry": "Kashanian, S, Khodaei, MM, Pakravan, P. Spectroscopic studies on the interaction of isatin with calf thymus DNA. DNA Cell Biol 2010; 29: 639–46. PMID: 20590475",
            "process_entry": "True",
            "doi": "10.1089/dna.2010.1054",
            "pmid": "20590475",
            "xmlid": "CIT0076"
        },
        {
            "bibentry": "Qiao, CY, Bi, SY, Sun, Y, et al. Study of interactions of anthraquinones with DNA using ethidium bromide as a fluorescence probe. Spectrochim Acta A Mol Biomol Spectrosc 2008; 70: 136–43. PMID: 17825605",
            "process_entry": "True",
            "doi": "10.1016/j.saa.2007.07.038",
            "pmid": "17825605",
            "xmlid": "CIT0077"
        },
        {
            "bibentry": "Tian, FF, Jiang, FL, Han, XL, et al. Synthesis of a novel hydrazone derivative and biophysical studies of its interactions with bovine serum albumin by spectroscopic, electrochemical, and molecular docking methods. J Phys Chem B 2010; 114: 14842–53. PMID: 21038894",
            "process_entry": "True",
            "doi": "10.1021/jp105766n",
            "pmid": "21038894",
            "xmlid": "CIT0078"
        },
        {
            "bibentry": "Khan, SN, Danishuddin, M, Khan, AU. Inhibition of transcription factor assembly and structural stability on mitoxantrone binding with DNA. Biosci Rep 2010; 30: 331–40. PMID: 19691448",
            "process_entry": "True",
            "doi": "10.1042/bsr20090083",
            "pmid": "19691448",
            "xmlid": "CIT0079"
        },
        {
            "bibentry": "Shahabadi, N, Fili, SM, Kheirdoosh, F. Study on the interaction of the drug mesalamine with calf thymus DNA using molecular docking and spectroscopic techniques. J Photochem Photobiol B Biol 2013; 128: 20–6.",
            "process_entry": "True",
            "xmlid": "CIT0080"
        },
        {
            "bibentry": "Rodger, A. Circular dichroism and linear dichroism. Encyclopedia of analytical chemistry. New York: John Wiley & Sons, Ltd; 2006.",
            "process_entry": "True",
            "xmlid": "CIT0081"
        },
        {
            "bibentry": "Ranjbar, B, Gill, P. Circular dichroism techniques: biomolecular and nanostructural analyses –a review. Chem Biol Drug Design 2009; 74: 101–20.",
            "process_entry": "True",
            "xmlid": "CIT0082"
        },
        {
            "bibentry": "Pabbathi, A, Samanta, A. Spectroscopic and molecular docking study of the interaction of DNA with a morpholinium ionic liquid. J Phys Chem B 2015; 119: 11099–105. PMID: 26061788",
            "process_entry": "True",
            "doi": "10.1021/acs.jpcb.5b02939",
            "pmid": "26061788",
            "xmlid": "CIT0083"
        },
        {
            "bibentry": "Nordén, B, Kurucsev, T. Analysing DNA complexes by circular and linear dichroism. J Mol Recognit 1994; 7: 141–55. PMID: 7826674",
            "process_entry": "True",
            "doi": "10.1002/jmr.300070211",
            "pmid": "7826674",
            "xmlid": "CIT0084"
        },
        {
            "bibentry": "Galindo, MA, Olea, D, Romero, MA, et al. Design and non-covalent DNA binding of platinum(II) metallacalix[4]arenes. Chem Eur J 2007; 13: 5075–81. PMID: 17465426",
            "process_entry": "True",
            "doi": "10.1002/chem.200601581",
            "pmid": "17465426",
            "xmlid": "CIT0085"
        },
        {
            "bibentry": "Pascu, GI, Hotze, ACG, Sanchez-Cano, C, et al. Dinuclear ruthenium(II) triple-stranded helicates: luminescent supramolecular cylinders that bind and coil DNA and exhibit activity against cancer cell lines. Angew Chem Int Ed 2007; 46: 4374–8.",
            "process_entry": "True",
            "xmlid": "CIT0086"
        },
        {
            "bibentry": "Hilovska, L, Jendzelovsky, R, Jendzelovska, Z, et al. Downregulation of BCRP and anti-apoptotic proteins by proadifen (SKF-525A) is responsible for the enhanced mitoxantrone accumulation and toxicity in mitoxantrone-resistant human promyelocytic leukemia cells. Int J Oncol 2015; 47: 1572–84. PMID: 26252082",
            "process_entry": "True",
            "doi": "10.3892/ijo.2015.3116",
            "pmid": "26252082",
            "xmlid": "CIT0087"
        },
        {
            "bibentry": "Jendzelovsky, R, Jendzelovska, Z, Hilovska, L, et al. Proadifen sensitizes resistant ovarian adenocarcinoma cells to cisplatin. Toxicol Lett 2016; 243: 56–66. PMID: 26721606",
            "process_entry": "True",
            "doi": "10.1016/j.toxlet.2015.12.002",
            "pmid": "26721606",
            "xmlid": "CIT0088"
        },
        {
            "bibentry": "Janockova, J, Plsikova, J, Kasparkova, J, et al. Inhibition of DNA topoisomerases I and II and growth inhibition of HL-60 cells by novel acridine-based compounds. Eur J Pharm Sci 2015; 76: 192–202. PMID: 25960253",
            "process_entry": "True",
            "doi": "10.1016/j.ejps.2015.04.023",
            "pmid": "25960253",
            "xmlid": "CIT0089"
        },
        {
            "bibentry": "Plsikova, J, Janovec, L, Koval, J, et al. 3,6-Bis(3-alkylguanidino)acridines as DNA-intercalating antitumor agents. Eur J Med Chem 2012; 57: 283–95. PMID: 23072739",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2012.09.020",
            "pmid": "23072739",
            "xmlid": "CIT0090"
        },
        {
            "bibentry": "Jenkins, TC. Optical absorbance and fluorescence techniques for measuring DNA-drug interactions. Meth Mol Biol 1997; 90: 195–218.",
            "process_entry": "True",
            "xmlid": "CIT0091"
        },
        {
            "bibentry": "McGhee, JD, von Hippel, PH. Theoretical aspects of DNA-protein interactions: co-operative and non-co-operative binding of large ligands to a one-dimensional homogeneous lattice. J Mol Biol 1974; 86: 469–89. PMID: 4416620",
            "process_entry": "True",
            "doi": "10.1016/0022-2836(74)90031-x",
            "pmid": "4416620",
            "xmlid": "CIT0092"
        },
        {
            "bibentry": "Lerman, LS. Structural considerations in the interaction of DNA and acridines. J Mol Biol 1961; 3: 18–IN4. PMID: 13761054",
            "process_entry": "True",
            "doi": "10.1016/s0022-2836(61)80004-1",
            "pmid": "13761054",
            "xmlid": "CIT0093"
        },
        {
            "bibentry": "Haris, P, Mary, V, Aparna, P, et al. A comprehensive approach to ascertain the binding mode of curcumin with DNA. Spectrochim Acta A Mol Biomol Spectrosc 2017; 175: 155–63. PMID: 28033562",
            "process_entry": "True",
            "doi": "10.1016/j.saa.2016.11.049",
            "pmid": "28033562",
            "xmlid": "CIT0094"
        },
        {
            "bibentry": "Gharagozlou, M, Boghaei, DM. Interaction of water-soluble amino acid Schiff base complexes with bovine serum albumin: fluorescence and circular dichroism studies. Spectrochim Acta A Mol Biomol Spectrosc 2008; 71: 1617–22. PMID: 18701343",
            "process_entry": "True",
            "doi": "10.1016/j.saa.2008.06.027",
            "pmid": "18701343",
            "xmlid": "CIT0095"
        },
        {
            "bibentry": "Rehman, SU, Sarwar, T, Husain, MA, et al. Studying non-covalent drug-DNA interactions. Arch Biochem Biophys 2015; 576: 49–60. PMID: 25951786",
            "process_entry": "True",
            "doi": "10.1016/j.abb.2015.03.024",
            "pmid": "25951786",
            "xmlid": "CIT0096"
        },
        {
            "bibentry": "Bielavsky, J. Analogs of 9-amino-1,2,3,4-tetrahydroacridine. Collect Czechoslovak Chem Commun 1977; 42: 2802–8.",
            "process_entry": "True",
            "xmlid": "CIT0097"
        },
        {
            "bibentry": "Mezeiova, E, Korabecny, J, Sepsova, V, et al. Development of 2-methoxyhuprine as novel lead for Alzheimer’s disease therapy. Molecules 2017; 22: 1–19.",
            "process_entry": "True",
            "xmlid": "CIT0098"
        }
    ],
    "localid": "MED-30938202",
    "doi": "10.1080/14756366.2019.1593159",
    "pmid": "10.1080/14756366.2019.1593159",
    "pmcid": "30938202",
    "curator": "BEE EuropeanPubMedCentralProcessor",
    "source_provider": "Europe PubMed Central",
    "source": "https://www.ebi.ac.uk/europepmc/webservices/rest/30938202/fullTextXML",
    "reference_pointers": [
        [
            {
                "n_rp": 0,
                "xref_id": "CIT0001",
                "rp_string": "1",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),1,156)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 1,
                "xref_id": "CIT0002",
                "rp_string": "2",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),1,156)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 2,
                "xref_id": "CIT0003",
                "rp_string": "3",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),308,10)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 3,
                "xref_id": "CIT0004",
                "rp_string": "4",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),430,148)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 4,
                "xref_id": "CIT0005",
                "rp_string": "5",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),579,68)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 5,
                "xref_id": "CIT0006",
                "rp_string": "6",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[7]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),648,156)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 6,
                "xref_id": "CIT0007",
                "rp_string": "7",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[8]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),805,110)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 7,
                "xref_id": "CIT0008",
                "rp_string": "8",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[9]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),916,63)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 8,
                "xref_id": "CIT0009",
                "rp_string": "9",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[10]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),980,250)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Tacrine (9-amino-1,2,3,4-tetrahydroacridine, THA, Figure 1) was first described as an analeptic able to cause rapid arousal of morphinized dogs and cats1,2. Later, THA was found to be a potent cholinesterase inhibitor of both acetylcholinesterase (AChE, E.C. 3.1.1.7) and butyrylcholinesterase (BuChE, E.C. 3.1.1.8)3. Notably, a potential crosstalk between some types of cancer and modulation of AChE activity has been proposed. Accordingly, the inhibition of AChE affecting cholinergic signaling has been associated with some potential benefits in e.g. cancerous lung tissue4. The effect of THA has been well-described in neurological diseases5. Indeed, THA was licensed in USA and Canada as the first symptomatic treatment for cognitive symptoms associated with Alzheimer’s disease (the drug Cognex)6. Clinical use of THA was limited due to its side effects, mainly hepatotoxicity and gastrointestinal symptoms7. The precise mechanism of hepatotoxicity still remains unclear8. Some researchers associate the THA-associated hepatotoxicity with oxidative bio-activation and the formation of chemically highly reactive metabolites9; however, the cell-killing effect is more probably mediated by membrane fluidity alterations10–12. Apart from that, mitochondrial dysfunction13 and necrosis of liver cells7 also emerged as other routes for THA toxicity.",
                "pl_xpath": "/article/body/sec[1]/p[1]"
            },
            {
                "n_rp": 10,
                "xref_id": "CIT0010",
                "rp_string": "10–12",
                "pl_string": "Tacrine (9-amino-1,2,3,4-tetrahydroacridine, THA, Figure 1) was first described as an analeptic able to cause rapid arousal of morphinized dogs and cats1,2. Later, THA was found to be a potent cholinesterase inhibitor of both acetylcholinesterase (AChE, E.C. 3.1.1.7) and butyrylcholinesterase (BuChE, E.C. 3.1.1.8)3. Notably, a potential crosstalk between some types of cancer and modulation of AChE activity has been proposed. Accordingly, the inhibition of AChE affecting cholinergic signaling has been associated with some potential benefits in e.g. cancerous lung tissue4. The effect of THA has been well-described in neurological diseases5. Indeed, THA was licensed in USA and Canada as the first symptomatic treatment for cognitive symptoms associated with Alzheimer’s disease (the drug Cognex)6. Clinical use of THA was limited due to its side effects, mainly hepatotoxicity and gastrointestinal symptoms7. The precise mechanism of hepatotoxicity still remains unclear8. Some researchers associate the THA-associated hepatotoxicity with oxidative bio-activation and the formation of chemically highly reactive metabolites9; however, the cell-killing effect is more probably mediated by membrane fluidity alterations10–12. Apart from that, mitochondrial dysfunction13 and necrosis of liver cells7 also emerged as other routes for THA toxicity.",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[11]",
                "pl_xpath": "/article/body/sec[1]/p[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),980,250)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 10,
                "xref_id": "CIT0010",
                "rp_string": "10–12",
                "pl_string": "Tacrine (9-amino-1,2,3,4-tetrahydroacridine, THA, Figure 1) was first described as an analeptic able to cause rapid arousal of morphinized dogs and cats1,2. Later, THA was found to be a potent cholinesterase inhibitor of both acetylcholinesterase (AChE, E.C. 3.1.1.7) and butyrylcholinesterase (BuChE, E.C. 3.1.1.8)3. Notably, a potential crosstalk between some types of cancer and modulation of AChE activity has been proposed. Accordingly, the inhibition of AChE affecting cholinergic signaling has been associated with some potential benefits in e.g. cancerous lung tissue4. The effect of THA has been well-described in neurological diseases5. Indeed, THA was licensed in USA and Canada as the first symptomatic treatment for cognitive symptoms associated with Alzheimer’s disease (the drug Cognex)6. Clinical use of THA was limited due to its side effects, mainly hepatotoxicity and gastrointestinal symptoms7. The precise mechanism of hepatotoxicity still remains unclear8. Some researchers associate the THA-associated hepatotoxicity with oxidative bio-activation and the formation of chemically highly reactive metabolites9; however, the cell-killing effect is more probably mediated by membrane fluidity alterations10–12. Apart from that, mitochondrial dysfunction13 and necrosis of liver cells7 also emerged as other routes for THA toxicity.",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[11]",
                "pl_xpath": "/article/body/sec[1]/p[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),980,250)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 11,
                "xref_id": "",
                "pl_string": "10–12",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[11]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),980,250)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 12,
                "xref_id": "",
                "pl_string": "10–12",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[11]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),980,250)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 13,
                "xref_id": "CIT0013",
                "rp_string": "13",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[12]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),1231,120)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 14,
                "xref_id": "CIT0005",
                "rp_string": "5",
                "rp_xpath": "/article/body/sec[1]/fig/caption/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/fig/caption/p),1,297)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Chemical structures of acridine (A), THA (B) and their derivatives: 7-MEOTA (C)5, mAMSA (D), 6-chloro-2-methoxy-N-{2-[4-(1,2,3,4-tetrahydroacridin-9-yl)piperazin-1-yl]ethyl}acridin-9-ylamine (E)35, 1-(1,2,3,4-tetrahydro-acridin-9-yl)-3-[2-(1,2,3,4-tetrahydroacridin-9-ylamino)ethyl]thiourea (F)35.",
                "pl_xpath": "/article/body/sec[1]/fig/caption/p"
            },
            {
                "n_rp": 15,
                "xref_id": "CIT0035",
                "rp_string": "35",
                "rp_xpath": "/article/body/sec[1]/fig/caption/p/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/fig/caption/p),1,297)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Chemical structures of acridine (A), THA (B) and their derivatives: 7-MEOTA (C)5, mAMSA (D), 6-chloro-2-methoxy-N-{2-[4-(1,2,3,4-tetrahydroacridin-9-yl)piperazin-1-yl]ethyl}acridin-9-ylamine (E)35, 1-(1,2,3,4-tetrahydro-acridin-9-yl)-3-[2-(1,2,3,4-tetrahydroacridin-9-ylamino)ethyl]thiourea (F)35.",
                "pl_xpath": "/article/body/sec[1]/fig/caption/p"
            },
            {
                "n_rp": 16,
                "xref_id": "CIT0035",
                "rp_string": "35",
                "rp_xpath": "/article/body/sec[1]/fig/caption/p/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/fig/caption/p),1,297)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Chemical structures of acridine (A), THA (B) and their derivatives: 7-MEOTA (C)5, mAMSA (D), 6-chloro-2-methoxy-N-{2-[4-(1,2,3,4-tetrahydroacridin-9-yl)piperazin-1-yl]ethyl}acridin-9-ylamine (E)35, 1-(1,2,3,4-tetrahydro-acridin-9-yl)-3-[2-(1,2,3,4-tetrahydroacridin-9-ylamino)ethyl]thiourea (F)35.",
                "pl_xpath": "/article/body/sec[1]/fig/caption/p"
            }
        ],
        [
            {
                "n_rp": 22,
                "xref_id": "CIT0014",
                "rp_string": "14–18",
                "pl_string": "14–18",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,255)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 18,
                "xref_id": "",
                "pl_string": "14–18",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,255)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 19,
                "xref_id": "",
                "pl_string": "14–18",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,255)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 20,
                "xref_id": "",
                "pl_string": "14–18",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,255)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 21,
                "xref_id": "",
                "pl_string": "14–18",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,255)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 22,
                "xref_id": "CIT0014",
                "rp_string": "14–18",
                "pl_string": "14–18",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,255)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 23,
                "xref_id": "CIT0019",
                "rp_string": "19",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),257,369)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "THA is currently used as a versatile scaffold in medicinal chemistry for designing novel hybrid compounds with improved pharmacological and toxicological profiles affecting several pathological mechanisms, e.g. in Alzheimer’s disease pathophysiology14–18. The THA derivative 7-MEOTA (7‐methoxy‐1,2,3,4‐tetrahydroacridin‐9‐amine, Figure 1), which was developed in our laboratory and primarily tested to antagonize anticholinergic syndrome evoked by scopolamine, ditrane and 3-quinuclidinyl benzilate19,20 and also as a prophylactic agent against organophosphate poisoning21, displayed a better toxicological profile than THA5. Mansouri et al.22 examined the mechanism of mitochondrial function damage during treatment with THA. Based on the chemical structure, it was postulated that THA might have a similar mechanism of action as the antitumor agent acridine (Figure 1) and related derivatives (e.g. mAMSA, imidazoacridinones, bis-tacrine, Figure 1)22. These acridines are able to intercalate between the planar bases of DNA and to inhibit nuclear type II topoisomerase (Topo II)23–26. In addition, a variety of bis-acridines have been developed with anticancer activity27,28. Further research also revealed that THA derivatives might be engaged also in interaction with type I topoisomerase (Topo I)29. THA itself was found to be a relatively weak catalytic inhibitor of Topo II implying inhibition of DNA synthesis. The latter led to depletion of mitochondrial DNA and ultimately to apoptosis22,29. Topo I and II are nuclear enzymes which play an important role by formatting superhelical DNA structures and thus ensuring essential cell functions. The topology of DNA can be regulated by certain enzymes leading to mutual transformation of its topological isomers and to the successive relaxation. Catalytic activity of topoisomerases lies in introduction DNA of single (Topo I) or double (Topo II) strand breaks. More recently, topoisomerases emerged as target of great interest in the development of novel antibacterial and anticancer drugs30,31.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            },
            {
                "n_rp": 24,
                "xref_id": "CIT0020",
                "rp_string": "20",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),257,369)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "THA is currently used as a versatile scaffold in medicinal chemistry for designing novel hybrid compounds with improved pharmacological and toxicological profiles affecting several pathological mechanisms, e.g. in Alzheimer’s disease pathophysiology14–18. The THA derivative 7-MEOTA (7‐methoxy‐1,2,3,4‐tetrahydroacridin‐9‐amine, Figure 1), which was developed in our laboratory and primarily tested to antagonize anticholinergic syndrome evoked by scopolamine, ditrane and 3-quinuclidinyl benzilate19,20 and also as a prophylactic agent against organophosphate poisoning21, displayed a better toxicological profile than THA5. Mansouri et al.22 examined the mechanism of mitochondrial function damage during treatment with THA. Based on the chemical structure, it was postulated that THA might have a similar mechanism of action as the antitumor agent acridine (Figure 1) and related derivatives (e.g. mAMSA, imidazoacridinones, bis-tacrine, Figure 1)22. These acridines are able to intercalate between the planar bases of DNA and to inhibit nuclear type II topoisomerase (Topo II)23–26. In addition, a variety of bis-acridines have been developed with anticancer activity27,28. Further research also revealed that THA derivatives might be engaged also in interaction with type I topoisomerase (Topo I)29. THA itself was found to be a relatively weak catalytic inhibitor of Topo II implying inhibition of DNA synthesis. The latter led to depletion of mitochondrial DNA and ultimately to apoptosis22,29. Topo I and II are nuclear enzymes which play an important role by formatting superhelical DNA structures and thus ensuring essential cell functions. The topology of DNA can be regulated by certain enzymes leading to mutual transformation of its topological isomers and to the successive relaxation. Catalytic activity of topoisomerases lies in introduction DNA of single (Topo I) or double (Topo II) strand breaks. More recently, topoisomerases emerged as target of great interest in the development of novel antibacterial and anticancer drugs30,31.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            },
            {
                "n_rp": 25,
                "xref_id": "CIT0021",
                "rp_string": "21",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),257,369)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "THA is currently used as a versatile scaffold in medicinal chemistry for designing novel hybrid compounds with improved pharmacological and toxicological profiles affecting several pathological mechanisms, e.g. in Alzheimer’s disease pathophysiology14–18. The THA derivative 7-MEOTA (7‐methoxy‐1,2,3,4‐tetrahydroacridin‐9‐amine, Figure 1), which was developed in our laboratory and primarily tested to antagonize anticholinergic syndrome evoked by scopolamine, ditrane and 3-quinuclidinyl benzilate19,20 and also as a prophylactic agent against organophosphate poisoning21, displayed a better toxicological profile than THA5. Mansouri et al.22 examined the mechanism of mitochondrial function damage during treatment with THA. Based on the chemical structure, it was postulated that THA might have a similar mechanism of action as the antitumor agent acridine (Figure 1) and related derivatives (e.g. mAMSA, imidazoacridinones, bis-tacrine, Figure 1)22. These acridines are able to intercalate between the planar bases of DNA and to inhibit nuclear type II topoisomerase (Topo II)23–26. In addition, a variety of bis-acridines have been developed with anticancer activity27,28. Further research also revealed that THA derivatives might be engaged also in interaction with type I topoisomerase (Topo I)29. THA itself was found to be a relatively weak catalytic inhibitor of Topo II implying inhibition of DNA synthesis. The latter led to depletion of mitochondrial DNA and ultimately to apoptosis22,29. Topo I and II are nuclear enzymes which play an important role by formatting superhelical DNA structures and thus ensuring essential cell functions. The topology of DNA can be regulated by certain enzymes leading to mutual transformation of its topological isomers and to the successive relaxation. Catalytic activity of topoisomerases lies in introduction DNA of single (Topo I) or double (Topo II) strand breaks. More recently, topoisomerases emerged as target of great interest in the development of novel antibacterial and anticancer drugs30,31.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            },
            {
                "n_rp": 26,
                "xref_id": "CIT0005",
                "rp_string": "5",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),257,369)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "THA is currently used as a versatile scaffold in medicinal chemistry for designing novel hybrid compounds with improved pharmacological and toxicological profiles affecting several pathological mechanisms, e.g. in Alzheimer’s disease pathophysiology14–18. The THA derivative 7-MEOTA (7‐methoxy‐1,2,3,4‐tetrahydroacridin‐9‐amine, Figure 1), which was developed in our laboratory and primarily tested to antagonize anticholinergic syndrome evoked by scopolamine, ditrane and 3-quinuclidinyl benzilate19,20 and also as a prophylactic agent against organophosphate poisoning21, displayed a better toxicological profile than THA5. Mansouri et al.22 examined the mechanism of mitochondrial function damage during treatment with THA. Based on the chemical structure, it was postulated that THA might have a similar mechanism of action as the antitumor agent acridine (Figure 1) and related derivatives (e.g. mAMSA, imidazoacridinones, bis-tacrine, Figure 1)22. These acridines are able to intercalate between the planar bases of DNA and to inhibit nuclear type II topoisomerase (Topo II)23–26. In addition, a variety of bis-acridines have been developed with anticancer activity27,28. Further research also revealed that THA derivatives might be engaged also in interaction with type I topoisomerase (Topo I)29. THA itself was found to be a relatively weak catalytic inhibitor of Topo II implying inhibition of DNA synthesis. The latter led to depletion of mitochondrial DNA and ultimately to apoptosis22,29. Topo I and II are nuclear enzymes which play an important role by formatting superhelical DNA structures and thus ensuring essential cell functions. The topology of DNA can be regulated by certain enzymes leading to mutual transformation of its topological isomers and to the successive relaxation. Catalytic activity of topoisomerases lies in introduction DNA of single (Topo I) or double (Topo II) strand breaks. More recently, topoisomerases emerged as target of great interest in the development of novel antibacterial and anticancer drugs30,31.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            }
        ],
        [
            {
                "n_rp": 27,
                "xref_id": "CIT0022",
                "rp_string": "22",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[7]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),627,100)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 28,
                "xref_id": "CIT0022",
                "rp_string": "22",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[10]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),728,226)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 33,
                "xref_id": "CIT0023",
                "rp_string": "23–26",
                "pl_string": "23–26",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[11]",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[11]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),955,132)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 30,
                "xref_id": "",
                "pl_string": "23–26",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[11]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),955,132)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 31,
                "xref_id": "",
                "pl_string": "23–26",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[11]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),955,132)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 32,
                "xref_id": "",
                "pl_string": "23–26",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[11]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),955,132)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 33,
                "xref_id": "CIT0023",
                "rp_string": "23–26",
                "pl_string": "23–26",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[11]",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[11]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),955,132)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 34,
                "xref_id": "CIT0027",
                "rp_string": "27",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[12]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1088,90)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 35,
                "xref_id": "CIT0028",
                "rp_string": "28",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[13]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1088,90)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 36,
                "xref_id": "CIT0029",
                "rp_string": "29",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[14]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1179,126)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 37,
                "xref_id": "CIT0022",
                "rp_string": "22",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[15]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1420,82)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 38,
                "xref_id": "CIT0029",
                "rp_string": "29",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[16]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1420,82)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 39,
                "xref_id": "CIT0030",
                "rp_string": "30",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[17]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1918,134)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 40,
                "xref_id": "CIT0031",
                "rp_string": "31",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[18]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1918,134)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 44,
                "xref_id": "CIT0032",
                "rp_string": "32–34",
                "pl_string": "32–34",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[1]",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),216,152)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 42,
                "xref_id": "",
                "pl_string": "32–34",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),216,152)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 43,
                "xref_id": "",
                "pl_string": "32–34",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),216,152)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 44,
                "xref_id": "CIT0032",
                "rp_string": "32–34",
                "pl_string": "32–34",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[1]",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),216,152)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 45,
                "xref_id": "CIT0035",
                "rp_string": "35",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),369,80)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 46,
                "xref_id": "CIT0036",
                "rp_string": "36",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),450,118)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 47,
                "xref_id": "CIT0037",
                "rp_string": "37",
                "rp_xpath": "/article/body/sec[1]/p[4]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[4]),174,249)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 48,
                "xref_id": "CIT0038",
                "rp_string": "38",
                "rp_xpath": "/article/body/sec[1]/p[4]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[4]),174,249)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 49,
                "xref_id": "CIT0001",
                "rp_string": "1",
                "rp_xpath": "/article/body/sec[2]/sec[1]/p[1]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/p[1]),79,255)",
                "containers_title": [
                    "Results and discussion",
                    "Chemistry"
                ]
            }
        ],
        [
            {
                "n_rp": 50,
                "xref_id": "CIT0039",
                "rp_string": "39",
                "rp_xpath": "/article/body/sec[2]/sec[1]/p[1]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/p[1]),335,145)",
                "containers_title": [
                    "Results and discussion",
                    "Chemistry"
                ]
            }
        ],
        [
            {
                "n_rp": 51,
                "xref_id": "CIT0040",
                "rp_string": "40",
                "rp_xpath": "/article/body/sec[2]/sec[1]/p[1]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/p[1]),335,145)",
                "containers_title": [
                    "Results and discussion",
                    "Chemistry"
                ]
            }
        ],
        [
            {
                "n_rp": 52,
                "xref_id": "CIT0041",
                "rp_string": "41",
                "rp_xpath": "/article/body/sec[2]/sec[1]/p[1]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/p[1]),948,135)",
                "containers_title": [
                    "Results and discussion",
                    "Chemistry"
                ]
            }
        ],
        [
            {
                "n_rp": 53,
                "xref_id": "CIT0042",
                "rp_string": "42",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[1]),201,183)",
                "containers_title": [
                    "Results and discussion",
                    "Biological evaluation"
                ]
            }
        ],
        [
            {
                "n_rp": 54,
                "xref_id": "CIT0043",
                "rp_string": "43",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p[1]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[1]),385,212)",
                "containers_title": [
                    "Results and discussion",
                    "Biological evaluation"
                ]
            }
        ],
        [
            {
                "n_rp": 55,
                "xref_id": "CIT0044",
                "rp_string": "44",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p[1]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[1]),1357,159)",
                "containers_title": [
                    "Results and discussion",
                    "Biological evaluation"
                ]
            }
        ],
        [
            {
                "n_rp": 56,
                "xref_id": "CIT0045",
                "rp_string": "45",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p[1]/xref[8]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[1]),2633,107)",
                "containers_title": [
                    "Results and discussion",
                    "Biological evaluation"
                ]
            }
        ],
        [
            {
                "n_rp": 57,
                "xref_id": "CIT0046",
                "rp_string": "46",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p[1]/xref[9]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[1]),2741,259)",
                "containers_title": [
                    "Results and discussion",
                    "Biological evaluation"
                ]
            }
        ],
        [
            {
                "n_rp": 58,
                "xref_id": "CIT0047",
                "rp_string": "47",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p[1]/xref[10]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[1]),3001,242)",
                "containers_title": [
                    "Results and discussion",
                    "Biological evaluation"
                ]
            }
        ],
        [
            {
                "n_rp": 59,
                "xref_id": "CIT0048",
                "rp_string": "48",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p[1]/xref[11]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[1]),3244,436)",
                "containers_title": [
                    "Results and discussion",
                    "Biological evaluation"
                ]
            }
        ],
        [
            {
                "n_rp": 60,
                "xref_id": "CIT0049",
                "rp_string": "49",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p[1]/xref[12]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[1]),3244,436)",
                "containers_title": [
                    "Results and discussion",
                    "Biological evaluation"
                ]
            }
        ],
        [
            {
                "n_rp": 61,
                "xref_id": "CIT0050",
                "rp_string": "50",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p[4]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[4]),1891,182)",
                "containers_title": [
                    "Results and discussion",
                    "Biological evaluation"
                ]
            }
        ],
        [
            {
                "n_rp": 65,
                "xref_id": "CIT0051",
                "rp_string": "51–53",
                "pl_string": "51–53",
                "rp_xpath": "/article/body/sec[2]/sec[3]/p/xref[1]",
                "pl_xpath": "/article/body/sec[2]/sec[3]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/p),352,146)",
                "containers_title": [
                    "Results and discussion",
                    "Activity of Topo I and II"
                ]
            },
            {
                "n_rp": 63,
                "xref_id": "",
                "pl_string": "51–53",
                "pl_xpath": "/article/body/sec[2]/sec[3]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/p),352,146)",
                "containers_title": [
                    "Results and discussion",
                    "Activity of Topo I and II"
                ]
            },
            {
                "n_rp": 64,
                "xref_id": "",
                "pl_string": "51–53",
                "pl_xpath": "/article/body/sec[2]/sec[3]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/p),352,146)",
                "containers_title": [
                    "Results and discussion",
                    "Activity of Topo I and II"
                ]
            }
        ],
        [
            {
                "n_rp": 65,
                "xref_id": "CIT0051",
                "rp_string": "51–53",
                "pl_string": "51–53",
                "rp_xpath": "/article/body/sec[2]/sec[3]/p/xref[1]",
                "pl_xpath": "/article/body/sec[2]/sec[3]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/p),352,146)",
                "containers_title": [
                    "Results and discussion",
                    "Activity of Topo I and II"
                ]
            }
        ],
        [
            {
                "n_rp": 66,
                "xref_id": "CIT0054",
                "rp_string": "54",
                "rp_xpath": "/article/body/sec[2]/sec[3]/p/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/p),641,123)",
                "containers_title": [
                    "Results and discussion",
                    "Activity of Topo I and II"
                ]
            }
        ],
        [
            {
                "n_rp": 70,
                "xref_id": "CIT0055",
                "rp_string": "55–57",
                "pl_string": "55–57",
                "rp_xpath": "/article/body/sec[2]/sec[3]/p/xref[3]",
                "pl_xpath": "/article/body/sec[2]/sec[3]/p/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/p),765,180)",
                "containers_title": [
                    "Results and discussion",
                    "Activity of Topo I and II"
                ]
            },
            {
                "n_rp": 68,
                "xref_id": "",
                "pl_string": "55–57",
                "pl_xpath": "/article/body/sec[2]/sec[3]/p/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/p),765,180)",
                "containers_title": [
                    "Results and discussion",
                    "Activity of Topo I and II"
                ]
            },
            {
                "n_rp": 69,
                "xref_id": "",
                "pl_string": "55–57",
                "pl_xpath": "/article/body/sec[2]/sec[3]/p/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/p),765,180)",
                "containers_title": [
                    "Results and discussion",
                    "Activity of Topo I and II"
                ]
            }
        ],
        [
            {
                "n_rp": 70,
                "xref_id": "CIT0055",
                "rp_string": "55–57",
                "pl_string": "55–57",
                "rp_xpath": "/article/body/sec[2]/sec[3]/p/xref[3]",
                "pl_xpath": "/article/body/sec[2]/sec[3]/p/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/p),765,180)",
                "containers_title": [
                    "Results and discussion",
                    "Activity of Topo I and II"
                ]
            }
        ],
        [
            {
                "n_rp": 71,
                "xref_id": "CIT0058",
                "rp_string": "58",
                "rp_xpath": "/article/body/sec[2]/sec[3]/p/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/p),946,183)",
                "containers_title": [
                    "Results and discussion",
                    "Activity of Topo I and II"
                ]
            }
        ],
        [
            {
                "n_rp": 72,
                "xref_id": "CIT0059",
                "rp_string": "59",
                "rp_xpath": "/article/body/sec[2]/sec[3]/sec[1]/p/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/sec[1]/p),1198,135)",
                "containers_title": [
                    "Results and discussion",
                    "Activity of Topo I and II",
                    "Effect on Topo I relaxation activity"
                ]
            }
        ],
        [
            {
                "n_rp": 73,
                "xref_id": "CIT0060",
                "rp_string": "60",
                "rp_xpath": "/article/body/sec[2]/sec[3]/sec[2]/p[1]/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/sec[2]/p[1]),257,177)",
                "containers_title": [
                    "Results and discussion",
                    "Activity of Topo I and II",
                    "Effect on Topo II decatenation activity and Topo II drug screening"
                ]
            }
        ],
        [
            {
                "n_rp": 74,
                "xref_id": "CIT0061",
                "rp_string": "61",
                "rp_xpath": "/article/body/sec[2]/sec[3]/sec[2]/p[2]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/sec[2]/p[2]),434,197)",
                "containers_title": [
                    "Results and discussion",
                    "Activity of Topo I and II",
                    "Effect on Topo II decatenation activity and Topo II drug screening"
                ]
            }
        ],
        [
            {
                "n_rp": 75,
                "xref_id": "CIT0062",
                "rp_string": "62",
                "rp_xpath": "/article/body/sec[2]/sec[3]/sec[2]/p[2]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/sec[2]/p[2]),993,192)",
                "containers_title": [
                    "Results and discussion",
                    "Activity of Topo I and II",
                    "Effect on Topo II decatenation activity and Topo II drug screening"
                ]
            }
        ],
        [
            {
                "n_rp": 76,
                "xref_id": "CIT0063",
                "rp_string": "63",
                "rp_xpath": "/article/body/sec[2]/sec[3]/sec[2]/p[3]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/sec[2]/p[3]),190,121)",
                "containers_title": [
                    "Results and discussion",
                    "Activity of Topo I and II",
                    "Effect on Topo II decatenation activity and Topo II drug screening"
                ]
            }
        ],
        [
            {
                "n_rp": 77,
                "xref_id": "CIT0060",
                "rp_string": "60",
                "rp_xpath": "/article/body/sec[2]/sec[3]/sec[2]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/sec[2]/p[3]),701,141)",
                "containers_title": [
                    "Results and discussion",
                    "Activity of Topo I and II",
                    "Effect on Topo II decatenation activity and Topo II drug screening"
                ]
            }
        ],
        [
            {
                "n_rp": 78,
                "xref_id": "CIT0064",
                "rp_string": "64",
                "rp_xpath": "/article/body/sec[2]/sec[3]/sec[2]/p[3]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/sec[2]/p[3]),701,141)",
                "containers_title": [
                    "Results and discussion",
                    "Activity of Topo I and II",
                    "Effect on Topo II decatenation activity and Topo II drug screening"
                ]
            }
        ],
        [
            {
                "n_rp": 79,
                "xref_id": "CIT0065",
                "rp_string": "65",
                "rp_xpath": "/article/body/sec[2]/sec[3]/sec[2]/p[3]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/sec[2]/p[3]),701,141)",
                "containers_title": [
                    "Results and discussion",
                    "Activity of Topo I and II",
                    "Effect on Topo II decatenation activity and Topo II drug screening"
                ]
            }
        ],
        [
            {
                "n_rp": 83,
                "xref_id": "CIT0066",
                "rp_string": "66–68",
                "pl_string": "66–68",
                "rp_xpath": "/article/body/sec[2]/sec[3]/sec[2]/p[3]/xref[5]",
                "pl_xpath": "/article/body/sec[2]/sec[3]/sec[2]/p[3]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/sec[2]/p[3]),843,141)",
                "containers_title": [
                    "Results and discussion",
                    "Activity of Topo I and II",
                    "Effect on Topo II decatenation activity and Topo II drug screening"
                ]
            },
            {
                "n_rp": 81,
                "xref_id": "",
                "pl_string": "66–68",
                "pl_xpath": "/article/body/sec[2]/sec[3]/sec[2]/p[3]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/sec[2]/p[3]),843,141)",
                "containers_title": [
                    "Results and discussion",
                    "Activity of Topo I and II",
                    "Effect on Topo II decatenation activity and Topo II drug screening"
                ]
            },
            {
                "n_rp": 82,
                "xref_id": "",
                "pl_string": "66–68",
                "pl_xpath": "/article/body/sec[2]/sec[3]/sec[2]/p[3]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/sec[2]/p[3]),843,141)",
                "containers_title": [
                    "Results and discussion",
                    "Activity of Topo I and II",
                    "Effect on Topo II decatenation activity and Topo II drug screening"
                ]
            }
        ],
        [
            {
                "n_rp": 83,
                "xref_id": "CIT0066",
                "rp_string": "66–68",
                "pl_string": "66–68",
                "rp_xpath": "/article/body/sec[2]/sec[3]/sec[2]/p[3]/xref[5]",
                "pl_xpath": "/article/body/sec[2]/sec[3]/sec[2]/p[3]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/sec[2]/p[3]),843,141)",
                "containers_title": [
                    "Results and discussion",
                    "Activity of Topo I and II",
                    "Effect on Topo II decatenation activity and Topo II drug screening"
                ]
            }
        ],
        [
            {
                "n_rp": 84,
                "xref_id": "CIT0069",
                "rp_string": "69",
                "rp_xpath": "/article/body/sec[2]/sec[4]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[4]/p[1]),193,261)",
                "containers_title": [
                    "Results and discussion",
                    "Spectroscopic properties"
                ]
            }
        ],
        [
            {
                "n_rp": 85,
                "xref_id": "CIT0070",
                "rp_string": "70",
                "rp_xpath": "/article/body/sec[2]/sec[4]/p[1]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[4]/p[1]),1335,369)",
                "containers_title": [
                    "Results and discussion",
                    "Spectroscopic properties"
                ],
                "pl_string": "Several binding modes have been identified between native and/or synthetic double-stranded DNA (dsDNA) and low molecular-weight compounds acting as chemotherapeutic agents or gene regulators. The non-covalent DNA interactions are represented mainly by intercalation between the base pairs of dsDNA; and binding to minor/major grooves of dsDNA, stabilized by a mix of electrostatic, hydrophobic, hydrogen-bonding interactions or outside random binding69. The interactions of 7-MEOTA-THA thio-/ureas 12–22 with ctDNA were studied in order to investigate their possible binding modes. Representative UV–vis absorption titration spectra for thiourea hybrid 17 and urea analog 22 are displayed in Figure 6. The addition of increasing amounts of ctDNA to a constant concentration of the compounds (UV–vis spectroscopic titration) revealed a hypochromic shift ranging from 16.31 to 46.10%. A mild bathochromic shift to higher wavelengths was observed only for compounds 17, 18, 20 and 21 (Δλ = 1 nm). The observed changes suggested that studied compounds 12–22 are able to interact with ctDNA, although from the small bathochromic shifts we can rather point out to groove binding or electrostatic interaction, rather than intercalation. The DNA-binding characteristics of the studied 7-MEOTA-THA thio-/ureas 12–22 are summarized in Table 2. The binding constants K of the studied compounds in complex with ctDNA ranged between 0.5 and 8.0 × 106 M−1 and were comparable with the measured K of acridine and greater than the literature-cited K for acridin-3,6-diyl dithiourea hydrochlorides (2.9–7.6 × 105 M−1)70, proflavine diureas (0.9–4.2 × 105 M−1)71 and tacrine derivatives with ctDNA (0.16–4.0 × 105 M−1)29. In addition, it is shown that linking of THA and 7-MEOTA with thio-/urea moieties positively influenced the interaction power. Binding constants typical for DNA intercalators lie in the range 104–106 M−1 and they are usually lower than binding constants typical for groove binders (range from 105 to 109 M−1).",
                "pl_xpath": "/article/body/sec[2]/sec[4]/p[1]"
            },
            {
                "n_rp": 86,
                "xref_id": "CIT0071",
                "rp_string": "71",
                "rp_xpath": "/article/body/sec[2]/sec[4]/p[1]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[4]/p[1]),1335,369)",
                "containers_title": [
                    "Results and discussion",
                    "Spectroscopic properties"
                ],
                "pl_string": "Several binding modes have been identified between native and/or synthetic double-stranded DNA (dsDNA) and low molecular-weight compounds acting as chemotherapeutic agents or gene regulators. The non-covalent DNA interactions are represented mainly by intercalation between the base pairs of dsDNA; and binding to minor/major grooves of dsDNA, stabilized by a mix of electrostatic, hydrophobic, hydrogen-bonding interactions or outside random binding69. The interactions of 7-MEOTA-THA thio-/ureas 12–22 with ctDNA were studied in order to investigate their possible binding modes. Representative UV–vis absorption titration spectra for thiourea hybrid 17 and urea analog 22 are displayed in Figure 6. The addition of increasing amounts of ctDNA to a constant concentration of the compounds (UV–vis spectroscopic titration) revealed a hypochromic shift ranging from 16.31 to 46.10%. A mild bathochromic shift to higher wavelengths was observed only for compounds 17, 18, 20 and 21 (Δλ = 1 nm). The observed changes suggested that studied compounds 12–22 are able to interact with ctDNA, although from the small bathochromic shifts we can rather point out to groove binding or electrostatic interaction, rather than intercalation. The DNA-binding characteristics of the studied 7-MEOTA-THA thio-/ureas 12–22 are summarized in Table 2. The binding constants K of the studied compounds in complex with ctDNA ranged between 0.5 and 8.0 × 106 M−1 and were comparable with the measured K of acridine and greater than the literature-cited K for acridin-3,6-diyl dithiourea hydrochlorides (2.9–7.6 × 105 M−1)70, proflavine diureas (0.9–4.2 × 105 M−1)71 and tacrine derivatives with ctDNA (0.16–4.0 × 105 M−1)29. In addition, it is shown that linking of THA and 7-MEOTA with thio-/urea moieties positively influenced the interaction power. Binding constants typical for DNA intercalators lie in the range 104–106 M−1 and they are usually lower than binding constants typical for groove binders (range from 105 to 109 M−1).",
                "pl_xpath": "/article/body/sec[2]/sec[4]/p[1]"
            },
            {
                "n_rp": 87,
                "xref_id": "CIT0029",
                "rp_string": "29",
                "rp_xpath": "/article/body/sec[2]/sec[4]/p[1]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[4]/p[1]),1335,369)",
                "containers_title": [
                    "Results and discussion",
                    "Spectroscopic properties"
                ],
                "pl_string": "Several binding modes have been identified between native and/or synthetic double-stranded DNA (dsDNA) and low molecular-weight compounds acting as chemotherapeutic agents or gene regulators. The non-covalent DNA interactions are represented mainly by intercalation between the base pairs of dsDNA; and binding to minor/major grooves of dsDNA, stabilized by a mix of electrostatic, hydrophobic, hydrogen-bonding interactions or outside random binding69. The interactions of 7-MEOTA-THA thio-/ureas 12–22 with ctDNA were studied in order to investigate their possible binding modes. Representative UV–vis absorption titration spectra for thiourea hybrid 17 and urea analog 22 are displayed in Figure 6. The addition of increasing amounts of ctDNA to a constant concentration of the compounds (UV–vis spectroscopic titration) revealed a hypochromic shift ranging from 16.31 to 46.10%. A mild bathochromic shift to higher wavelengths was observed only for compounds 17, 18, 20 and 21 (Δλ = 1 nm). The observed changes suggested that studied compounds 12–22 are able to interact with ctDNA, although from the small bathochromic shifts we can rather point out to groove binding or electrostatic interaction, rather than intercalation. The DNA-binding characteristics of the studied 7-MEOTA-THA thio-/ureas 12–22 are summarized in Table 2. The binding constants K of the studied compounds in complex with ctDNA ranged between 0.5 and 8.0 × 106 M−1 and were comparable with the measured K of acridine and greater than the literature-cited K for acridin-3,6-diyl dithiourea hydrochlorides (2.9–7.6 × 105 M−1)70, proflavine diureas (0.9–4.2 × 105 M−1)71 and tacrine derivatives with ctDNA (0.16–4.0 × 105 M−1)29. In addition, it is shown that linking of THA and 7-MEOTA with thio-/urea moieties positively influenced the interaction power. Binding constants typical for DNA intercalators lie in the range 104–106 M−1 and they are usually lower than binding constants typical for groove binders (range from 105 to 109 M−1).",
                "pl_xpath": "/article/body/sec[2]/sec[4]/p[1]"
            }
        ],
        [
            {
                "n_rp": 88,
                "xref_id": "CIT0072",
                "rp_string": "72",
                "rp_xpath": "/article/body/sec[2]/sec[4]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[4]/p[2]),229,113)",
                "containers_title": [
                    "Results and discussion",
                    "Spectroscopic properties"
                ]
            }
        ],
        [
            {
                "n_rp": 89,
                "xref_id": "CIT0072",
                "rp_string": "72",
                "rp_xpath": "/article/body/sec[2]/sec[4]/p[2]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[4]/p[2]),1208,98)",
                "containers_title": [
                    "Results and discussion",
                    "Spectroscopic properties"
                ]
            }
        ],
        [
            {
                "n_rp": 90,
                "xref_id": "CIT0073",
                "rp_string": "73",
                "rp_xpath": "/article/body/sec[2]/sec[4]/p[2]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[4]/p[2]),1307,165)",
                "containers_title": [
                    "Results and discussion",
                    "Spectroscopic properties"
                ]
            }
        ],
        [
            {
                "n_rp": 91,
                "xref_id": "CIT0074",
                "rp_string": "74",
                "rp_xpath": "/article/body/sec[2]/sec[4]/p[4]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[4]/p[4]),528,128)",
                "containers_title": [
                    "Results and discussion",
                    "Spectroscopic properties"
                ]
            }
        ],
        [
            {
                "n_rp": 92,
                "xref_id": "CIT0075",
                "rp_string": "75",
                "rp_xpath": "/article/body/sec[2]/sec[4]/p[4]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[4]/p[4]),1179,145)",
                "containers_title": [
                    "Results and discussion",
                    "Spectroscopic properties"
                ]
            }
        ],
        [
            {
                "n_rp": 93,
                "xref_id": "CIT0076",
                "rp_string": "76",
                "rp_xpath": "/article/body/sec[2]/sec[4]/p[4]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[4]/p[4]),1179,145)",
                "containers_title": [
                    "Results and discussion",
                    "Spectroscopic properties"
                ]
            }
        ],
        [
            {
                "n_rp": 94,
                "xref_id": "CIT0077",
                "rp_string": "77",
                "rp_xpath": "/article/body/sec[2]/sec[4]/p[4]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[4]/p[4]),1891,53)",
                "containers_title": [
                    "Results and discussion",
                    "Spectroscopic properties"
                ]
            }
        ],
        [
            {
                "n_rp": 95,
                "xref_id": "CIT0078",
                "rp_string": "78",
                "rp_xpath": "/article/body/sec[2]/sec[4]/p[4]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[4]/p[4]),1891,53)",
                "containers_title": [
                    "Results and discussion",
                    "Spectroscopic properties"
                ]
            }
        ],
        [
            {
                "n_rp": 96,
                "xref_id": "CIT0079",
                "rp_string": "79",
                "rp_xpath": "/article/body/sec[2]/sec[4]/p[5]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[4]/p[5]),791,142)",
                "containers_title": [
                    "Results and discussion",
                    "Spectroscopic properties"
                ]
            }
        ],
        [
            {
                "n_rp": 97,
                "xref_id": "CIT0080",
                "rp_string": "80",
                "rp_xpath": "/article/body/sec[2]/sec[4]/p[5]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[4]/p[5]),791,142)",
                "containers_title": [
                    "Results and discussion",
                    "Spectroscopic properties"
                ]
            }
        ],
        [
            {
                "n_rp": 98,
                "xref_id": "CIT0081",
                "rp_string": "81",
                "rp_xpath": "/article/body/sec[2]/sec[4]/p[6]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[4]/p[6]),401,327)",
                "containers_title": [
                    "Results and discussion",
                    "Spectroscopic properties"
                ]
            }
        ],
        [
            {
                "n_rp": 99,
                "xref_id": "CIT0082",
                "rp_string": "82",
                "rp_xpath": "/article/body/sec[2]/sec[4]/p[6]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[4]/p[6]),729,163)",
                "containers_title": [
                    "Results and discussion",
                    "Spectroscopic properties"
                ]
            }
        ],
        [
            {
                "n_rp": 100,
                "xref_id": "CIT0083",
                "rp_string": "83",
                "rp_xpath": "/article/body/sec[2]/sec[4]/p[6]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[4]/p[6]),1326,164)",
                "containers_title": [
                    "Results and discussion",
                    "Spectroscopic properties"
                ]
            }
        ],
        [
            {
                "n_rp": 101,
                "xref_id": "CIT0071",
                "rp_string": "71",
                "rp_xpath": "/article/body/sec[2]/sec[4]/p[6]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[4]/p[6]),1800,348)",
                "containers_title": [
                    "Results and discussion",
                    "Spectroscopic properties"
                ]
            }
        ],
        [
            {
                "n_rp": 102,
                "xref_id": "CIT0084",
                "rp_string": "84",
                "rp_xpath": "/article/body/sec[2]/sec[4]/p[7]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[4]/p[7]),747,199)",
                "containers_title": [
                    "Results and discussion",
                    "Spectroscopic properties"
                ]
            }
        ],
        [
            {
                "n_rp": 103,
                "xref_id": "CIT0085",
                "rp_string": "85",
                "rp_xpath": "/article/body/sec[2]/sec[4]/p[7]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[4]/p[7]),947,263)",
                "containers_title": [
                    "Results and discussion",
                    "Spectroscopic properties"
                ]
            }
        ],
        [
            {
                "n_rp": 104,
                "xref_id": "CIT0086",
                "rp_string": "86",
                "rp_xpath": "/article/body/sec[2]/sec[4]/p[7]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[4]/p[7]),947,263)",
                "containers_title": [
                    "Results and discussion",
                    "Spectroscopic properties"
                ]
            }
        ],
        [
            {
                "n_rp": 105,
                "xref_id": "CIT0084",
                "rp_string": "84",
                "rp_xpath": "/article/body/sec[2]/sec[4]/p[7]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[4]/p[7]),1333,200)",
                "containers_title": [
                    "Results and discussion",
                    "Spectroscopic properties"
                ]
            }
        ],
        [
            {
                "n_rp": 106,
                "xref_id": "CIT0087",
                "rp_string": "87",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[2]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[2]/p[1]),1,356)",
                "containers_title": [
                    "Experimental",
                    "Methods",
                    "Flow cytometry analysis"
                ]
            }
        ],
        [
            {
                "n_rp": 107,
                "xref_id": "CIT0088",
                "rp_string": "88",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[2]/p[1]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[2]/p[1]),1,356)",
                "containers_title": [
                    "Experimental",
                    "Methods",
                    "Flow cytometry analysis"
                ]
            }
        ],
        [
            {
                "n_rp": 108,
                "xref_id": "CIT0089",
                "rp_string": "89",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[2]/p[3]/xref",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[2]/p[3]),240,74)",
                "containers_title": [
                    "Experimental",
                    "Methods",
                    "Flow cytometry analysis"
                ]
            }
        ],
        [
            {
                "n_rp": 109,
                "xref_id": "CIT0087",
                "rp_string": "87",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[2]/p[4]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[2]/p[4]),294,111)",
                "containers_title": [
                    "Experimental",
                    "Methods",
                    "Flow cytometry analysis"
                ]
            }
        ],
        [
            {
                "n_rp": 110,
                "xref_id": "CIT0089",
                "rp_string": "89",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[2]/p[4]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[2]/p[4]),294,111)",
                "containers_title": [
                    "Experimental",
                    "Methods",
                    "Flow cytometry analysis"
                ]
            }
        ],
        [
            {
                "n_rp": 111,
                "xref_id": "CIT0029",
                "rp_string": "29",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[5]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[5]/p),1,161)",
                "containers_title": [
                    "Experimental",
                    "Methods",
                    "Topoisomerase I-mediated supercoiled pUC19 relaxation"
                ]
            }
        ],
        [
            {
                "n_rp": 112,
                "xref_id": "CIT0090",
                "rp_string": "90",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[5]/p/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[5]/p),1,161)",
                "containers_title": [
                    "Experimental",
                    "Methods",
                    "Topoisomerase I-mediated supercoiled pUC19 relaxation"
                ]
            }
        ],
        [
            {
                "n_rp": 113,
                "xref_id": "CIT0029",
                "rp_string": "29",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[6]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[6]/p),273,77)",
                "containers_title": [
                    "Experimental",
                    "Methods",
                    "Influence of derivatives on topoisomerase II decatenation"
                ]
            }
        ],
        [
            {
                "n_rp": 114,
                "xref_id": "CIT0090",
                "rp_string": "90",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[6]/p/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[6]/p),273,77)",
                "containers_title": [
                    "Experimental",
                    "Methods",
                    "Influence of derivatives on topoisomerase II decatenation"
                ]
            }
        ],
        [
            {
                "n_rp": 115,
                "xref_id": "CIT0029",
                "rp_string": "29",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[7]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[7]/p),168,219)",
                "containers_title": [
                    "Experimental",
                    "Methods",
                    "Topoisomerase II-mediated DNA cleavage assay"
                ]
            }
        ],
        [
            {
                "n_rp": 116,
                "xref_id": "CIT0090",
                "rp_string": "90",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[7]/p/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[7]/p),168,219)",
                "containers_title": [
                    "Experimental",
                    "Methods",
                    "Topoisomerase II-mediated DNA cleavage assay"
                ]
            }
        ],
        [
            {
                "n_rp": 117,
                "xref_id": "CIT0091",
                "rp_string": "91",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[8]/p[2]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[8]/p[2]),492,87)",
                "containers_title": [
                    "Experimental",
                    "Methods",
                    "UV–vis absorption spectroscopy and determination of binding constants"
                ]
            }
        ],
        [
            {
                "n_rp": 118,
                "xref_id": "CIT0092",
                "rp_string": "92",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[8]/p[2]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[8]/p[2]),580,487)",
                "containers_title": [
                    "Experimental",
                    "Methods",
                    "UV–vis absorption spectroscopy and determination of binding constants"
                ]
            }
        ],
        [
            {
                "n_rp": 119,
                "xref_id": "CIT0073",
                "rp_string": "73",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[10]/p[2]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[10]/p[2]),1,367)",
                "containers_title": [
                    "Experimental",
                    "Methods",
                    "Fluorescence spectroscopy"
                ]
            }
        ],
        [
            {
                "n_rp": 120,
                "xref_id": "CIT0093",
                "rp_string": "93",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[10]/p[2]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[10]/p[2]),369,250)",
                "containers_title": [
                    "Experimental",
                    "Methods",
                    "Fluorescence spectroscopy"
                ]
            }
        ],
        [
            {
                "n_rp": 121,
                "xref_id": "CIT0094",
                "rp_string": "94",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[10]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[10]/p[3]),1,234)",
                "containers_title": [
                    "Experimental",
                    "Methods",
                    "Fluorescence spectroscopy"
                ]
            }
        ],
        [
            {
                "n_rp": 122,
                "xref_id": "CIT0095",
                "rp_string": "95",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[10]/p[4]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[10]/p[4]),1,308)",
                "containers_title": [
                    "Experimental",
                    "Methods",
                    "Fluorescence spectroscopy"
                ]
            }
        ],
        [
            {
                "n_rp": 123,
                "xref_id": "CIT0096",
                "rp_string": "96",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[10]/p[4]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[10]/p[4]),421,111)",
                "containers_title": [
                    "Experimental",
                    "Methods",
                    "Fluorescence spectroscopy"
                ]
            }
        ],
        [
            {
                "n_rp": 124,
                "xref_id": "CIT0039",
                "rp_string": "39",
                "rp_xpath": "/article/body/sec[3]/sec[3]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/p),1,163)",
                "containers_title": [
                    "Experimental",
                    "Chemistry"
                ]
            }
        ],
        [
            {
                "n_rp": 125,
                "xref_id": "CIT0097",
                "rp_string": "97",
                "rp_xpath": "/article/body/sec[3]/sec[3]/p/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/p),1,163)",
                "containers_title": [
                    "Experimental",
                    "Chemistry"
                ]
            }
        ],
        [
            {
                "n_rp": 126,
                "xref_id": "CIT0098",
                "rp_string": "98",
                "rp_xpath": "/article/body/sec[3]/sec[3]/p/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/p),1,163)",
                "containers_title": [
                    "Experimental",
                    "Chemistry"
                ]
            }
        ]
    ]
}